Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
46.58
-0.31 (-0.66%)
At close: Nov 20, 2024, 4:00 PM
45.00
-1.58 (-3.39%)
Pre-market: Nov 21, 2024, 5:25 AM EST
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 244 employees as of December 31, 2023. The number of employees increased by 157 or 180.46% compared to the previous year.
Employees
244
Change (1Y)
157
Growth (1Y)
180.46%
Revenue / Employee
$531,234
Profits / Employee
-$550,586
Market Cap
1.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 18,000 |
| Integra LifeSciences Holdings | 3,946 |
| Tandem Diabetes Care | 2,400 |
| NovoCure | 1,453 |
| AtriCure | 1,200 |
| Galapagos NV | 1,123 |
| Recursion Pharmaceuticals | 500 |
| RxSight | 374 |
TARS News
- 7 days ago - Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors - GlobeNewsWire
- 14 days ago - Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - GlobeNewsWire
- 16 days ago - Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewsWire
- 5 weeks ago - Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% - GlobeNewsWire
- 2 months ago - Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024 - GlobeNewsWire
- 2 months ago - Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations - Seeking Alpha
- 3 months ago - Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference - GlobeNewsWire